Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
BMC Cancer|February 2, 2020
Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutationsRoberto Ruiz-Cordero, Junsheng Ma, Abha Khanna, et al.
Haematologica|August 20, 2016
Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemiaBetül Oran, Jeff L Jorgensen, David Marin, et al.
British Journal of Haematology|January 22, 2013
Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantationFleur M Aung, Benjamin Lichtiger, Roland Bassett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2025
Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory LymphomaYago Nieto, Jeremy Ramdial, Benigno Valdez, et al.
JAMA Dermatology|March 11, 2026
Diagnostic Accuracy of Dermoscopic Features in Acral Lentiginous Melanoma: A Systematic Review and Meta-analysisChidimma J Okwara, T Austin Black, Priscilla L Haff, et al.
The Lancet. Haematology|May 20, 2017
High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalanYago Nieto, Benigno C Valdez, Sai R Pingali, et al.
Therapeutic Advances in Medical Oncology|October 21, 2025
A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease)Bora Lim, Angela Marx, Megumi Kai, et al.
Oncotarget|August 7, 2019
Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinomaOmkara Lakshmi Veeranki, Zhimin Tong, Rashmi Dokey, et al.
Leukemia|July 27, 2021
Decrease post-transplant relapse using donor-derived expanded NK-cellsStefan O Ciurea, Piyanuch Kongtim, Doris Soebbing, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 4, 2015
Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell TransplantationBetül Oran, Antonio M Jimenez, Marcos De Lima, et al.
Pageof 15